Stay informed with the latest litigation news. Explore now

IP Verse

Concert Pharmaceuticals competitive analysis

Latest publications and patents of Concert Pharmaceuticals New

Explore the latest publications and patents granted to Concert Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 1, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Concert Pharmaceuticals

EP3450434
Feb 24, 2021Deuterated Derivatives Of RuxolitinibGranted And Under Opposition
EP3093290
Jan 24, 2018Morphinan CompoundsNo Opposition Filed Within Time Limit
EP2365808
Jan 10, 2018Combination Of Morphinan Compounds And Antidepressant For The Treatment Of Pseudobulbar Affect, Neurological Diseases, Intractable And Chronic Pain And Brain InjuryNo Opposition Filed Within Time Limit

Latest oppositions filed by Concert Pharmaceuticals

Explore patent oppositions filed by Concert Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 4, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP2635299
Methods For Treating Hair Loss DisordersTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKApr 30, 2020
EP3184526
Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase InhibitorINCYTEJun 28, 2019

Latest patents of Concert Pharmaceuticals opposed by its competitors

Explore Concert Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 4, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3450434
Feb 24, 2021Deuterated Derivatives Of Ruxolitinib1

Top competitors of Concert Pharmaceuticals

Top competitors of Concert Pharmaceuticals based on patent oppositions.